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Newsletter is a publication of the
Maryland Health Care Ethics
Committee Network, an initiative of
the University of Maryland Francis
King Carey School of Law’s Law &
Health Care Program. The Newsletter
combines educational articles with
timely information about bioethics
activities. Each issue includes a feature
article, a Calendar of upcoming
events, and a case presentation and
commentary by local experts in
bioethics, law, medicine, nursing, or
related disciplines.
Diane E. Hoffmann, JD, MS - Editor

Michael Lewis’ bestselling book “The Undoing Project” (2016) chronicles the
friendship and partnership of Israeli psychologists Dan Kahneman and Amos
Tversky, whose research on systematic errors in human judgment jump-started the
field of behavioral economics. In the book, Lewis recounts the story of how internist
Don Redelmeier took on the role of checking trauma specialists’ decisions for
systematic mental errors known as “heuristic biases.” An example Lewis provides
is a patient admitted to Redelmeier’s trauma center with multiple fractures from a
motor vehicle accident. The patient developed a heart arrhythmia. Upon mentioning
to her physicians that she had a history of hyperthyroidism, they concluded
that this was causing her arrhythmia. Redelmeier encouraged the physicians to
pause, check their thinking, and consider more statistically probable causes of the
arrhythmia. Indeed, they discovered a collapsed lung, which hadn’t shown up on
X-ray. The physicians’ failure to consider a collapsed lung is an example of the
“representativeness heuristic” clouding the physicians’ judgment—that is, making
a judgment based on resemblance of the situation to one fresh in the mind, without
regard to statistical probabilities.
Implications of Kahneman and Tversky’s research are relevant for the field
of medicine, and in turn, for those responding to ethics consultation requests.
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Just as the physicians Redelmeier
interacted with fell prey to their error
judgments, health care professionals
in all disciplines and practice settings
are prone to similar errors. The idea
isn’t to defer to algorithms alone
and mistrust all human judgments.
Medicine and ethical decision-making
are context-specific, and will always
require experts to assemble and make
meaning of relevant information. But
Kahneman and Tversky’s research
(and that of others in the field)
demonstrates the benefits of pausing
to consider ways in which known
heuristic biases may influence the
judgment of experts involved in a
case. [See Box p. 3] Is treatment for
the elderly patient in the intensive
care unit truly non-beneficial, or could
it be that the patient brings to mind
others whose dying and suffering were
prolonged unnecessarily? Simply
pausing to consider that possibility
could be helpful, and something an
ethics consultation service could
provide. As Redelmeier, cited by
Lewis (2016), stated: “Wherever
there is uncertainty there has got to
be judgment … and wherever there is
judgment there is an opportunity for
human fallibility.”
How might this area of research
influence clinicians’—and ethics
consultants’—communication
with patients and family members?
Related research in the field of
human decision-making and “choice
architecture” has focused on the
use of “nudges” that take advantage
of cognitive biases to influence
individuals’ decisions and actions
(Ploug & Holm, 2015; Thaler &
Sustein, 2008). Examples of some
cognitive biases are listed in the Box
on page 3. An example of a "nudge"
to counteract a bias would be to frame
the effects of an intervention the
clinician recommends as a gain, and
an intervention the clinician doesn't
recommend as a loss (e.g., "95% of
patients who were treated with [X]
had no benefit, so I don't recommend

it" or "25% of patients who were
treated with [X] lived at least another
five years, so that is something I'd
recommend for you"). Some consider
the use of nudges to be an effective
tool of persuasion, allowing clinicians
to fulfill duties of beneficence toward
patients. Others wonder whether this
crosses over into manipulation or even
coercion (Blumenthal-Barby, 2016),
perhaps causing clinicians to violate
their duty to respect patient autonomy.
Thus, this area is ripe for ethics
committee members to appraise.
Anita J. Tarzian, PhD, RN
MHECN Program Coordinator
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BOX 1.
HEURISTIC/BIAS
AFFECT
AMBIGUITY AVERSION
ANCHORING
AVAILABILITY
BANDWAGON
COMMISSION
CONFIRMATION
DECOY
DEFAULT/STATUS QUO
FREQUENCY/FRAMING
EFFECT
IMPACT
LOSS/GAIN FRAMING
OMISSION
OPTIMISM
ORDER EFFECTS
OUTCOME
RELATIVE RISK

REPRESENTATIVENESS
SUNK-COST

DEFINITION/EXAMPLE
Judgment is influenced by a feeling (affect) associated with a decision or action (e.g., patient
rejects hospice due to its association with death)
Preferring known risks over unknown risks regardless of actual benefits (e.g., hospital counsel
favors a current ICU policy associated with known litigation rate over new policy expected to
lower litigious actions but for which the actual impact on litigation is unknown)
Relying too heavily on the first piece of information offered (e.g., family told a patient’s
condition is stable interpret future diagnostic information more favorably)
Giving more weight to recent or more easily recalled information (e.g., surrogate who had
poor experience with staff more likely to appraise other staff’s behavior negatively)
Favoring decisions or actions that are more popularly supported (e.g., concluding a
controversial opinion is right because everyone else on the ethics committee has agreed)
Favoring action rather than inaction (e.g., internist orders diagnostic tests that won’t change
the patient’s end-of-life care)
Gathering & filtering information to support one’s pre-existing beliefs (e.g., clinician
assembles data only on poor outcomes of extremely low birthweight infants to support
position to favor comfort care)
Changing one’s preference between two options when a third “decoy” option is presented
(e.g., reconsidering paying more for a better but costlier drug when a third more expensive
drug is offered)
Preferring the current situation regardless of outcomes (e.g., family selects to keep dying
patient in the ICU even though goals of treatment would be better achieved elsewhere)
Preferring a decision or action presented as a gain over one presented as a loss (e.g. patients
told they have a 5% chance of cure more likely to choose treatment than those told there’s a
95% chance it will not work)
Overestimating the long-term impact of positive and negative events (e.g., healthy individuals
appraise future disability more negatively than those who are disabled)
Preferring avoiding loss rather than acquiring gains (e.g., those told inactivity will take 3 years
off their lifespan are more likely to exercise than those told exercise will add 3 years to their
lifespan)
Judging harmful commissions as worse than corresponding omissions (e.g., parents view
harms associated with vaccinating their child as worse than harm of foregoing vaccinations,
despite data to contrary)
Judging that one has a lesser risk of experiencing a negative event compared to others (e.g.,
parents who don’t vaccinate their child are confident this will not cause harm to the child or to
others)
Choosing information presented at the beginning or end of a series more often than
information presented in the middle of the series (e.g., patients order healthier foods from
hospital menus when healthy choices come first)
Allowing a prior event or decision outcome to influence subsequent independent decisions
(e.g., a clinician chooses a more expensive drug for a patient simply because a prior patient
had a bad reaction to the generic version)
Being more likely to act when presented with the relative risk of something (e.g., inactive
women are 25% more likely to develop breast cancer than women who exercise) than when
presented with its absolute risk (e.g., 500 women per 100,000 who are inactive develop breast
cancer annually)
Making a judgment based on resemblance of the situation to one fresh in the mind, instead
of considering the laws of probability (e.g., assuming the delirious patient in the emergency
department with a long history of alcoholism is intoxicated)
Choosing to continue an undertaking because money, time, or effort has been invested (e.g.,
clinicians of a patient considered terminal after 3 months in the ICU continue life-prolonging
interventions based on desire for efforts not to be wasted)

Thaler, R. H., & Sunstein, C. R. (2008). Nudge: Improving Decisions about Health, Wealth, and Happiness. New Haven, CT: Yale University Press.
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ANA UPDATES POSITION ON NUTRITION & HYDRATION
AT END OF LIFE
The American
Nurses
Association’s
(ANA) Center
for Ethics and
Human Rights
has revised its
position statement
on Nutrition and
Hydration at
the End of Life
(ANA, 2017).
The new position
recognizes
the right of
decisionally
capable patients
to voluntarily stop
eating and drinking (VSED) as
a means to hasten their death.
Specifically, it states: “The
decision to voluntarily stop eating
and drinking … with the intention
of hastening death can be made
only by those patients with
decision-making capacity, not by
surrogates. A patient’s decision
regarding VSED remains binding,
even if the patient subsequently
loses capacity.”
The ANA considers a nurse’s
involvement in assisted suicide
and euthanasia to constitute a
violation of the nursing Code of
Ethics (ANA, 2015). Specifically,
the Code’s Provision 1, that the
“nurse practices with compassion
and respect for the inherent
dignity, worth, and unique
attributes of every person” (p.
1) requires that nurses “should
provide interventions to relieve
pain and other symptoms in the
dying patient consistent with
palliative care practice standards
and may not act with the sole
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intent to end life” (Provision 1.4 in
the Code's Interpretive Statements,
p. 3). Thus, the Code acknowledges
that providing support and symptom
management to the patient who
chooses VSED to hasten his or her
own death does not constitute acting
“with the sole intent to end life,” but
that participating in assisted suicide
is a “direct violation” of the Code,
“the ethical traditions and goals of
the profession, and its covenant with
society” (ANA, 2013). For states
where assistance in dying is legal,
such as Oregon (i.e., adults in those
states deemed terminally ill can
legally access a lethal prescription to
hasten their death if they go through
certain procedural steps), the ANA
acknowledges ways nurses may stay
involved, such as explaining state
laws to patients, discussing options
regarding end-of-life decisions with
them, exploring reasons for the
patient’s request to hasten his or her
death, and following up accordingly.
VSED offers an option for legally
hastening one’s death in states where

access to a lethal
prescription is not
available. Schwarz
(2017) explains
that this route
requires a person’s
firm commitment
to forego nutrition
and hydration by
mouth—a process
that typically leads to
death by dehydration
generally within two
weeks or longer if
the person continues
to ingest fluids. This
approach to hastening
death requires
palliative support, including good
oral hygiene, symptom management,
and family support. For those worried
about losing the capacity to choose
VSED (e.g., individuals in the later
stages of Alzheimer’s who continue
accepting spoon feedings), Schwarz
(2017) proposes specific language
to include in an advance directive to
allow caregivers to withhold spoon
feeding, particularly if it appears
“reflexive” and is not providing
comfort or pleasure. The ANA’s
revised position provides support for
this position, although determining
whether a person with dementia
is “reflexively” eating may be
challenging.
REFERENCES
Schwarz, J. (2017). Hospice care for
patients who choose to hasten death
by voluntarily stopping eating and
drinking. Southeast VSED End-ofLife Choice conference. Available at
https://vsed-2017.net/resources/.

EMPATHY: IN THEORY AND IN PRACTICE
Back in the days of “doctor
knows best,” empathy was of little
value when deciding how to care
for a patient. Why bother seriously
considering what the patient might
be going through since the doctor’s
recommendation was the final word
in patient care? The patient could
either accept the recommendation or
go elsewhere—making the question,
“What is the patient experiencing?”
unimportant. Today, however, both
patients and medical professionals see
empathy as an essential part of good
clinical medicine. But, I have come
to wonder if we clinical ethicists
have an adequate understanding
of empathy. It seems to be both an
essential practice and a perplexing
concept in need of clarity.
When I began thinking about the
role of empathy in medicine and
clinical ethics, I began by looking
at the word itself. Our English
word “empathy” came from the
German term Einfühlung—a word
rooted in the Greek term empátheia.
The German word began carrying
philosophical and theological weight
in Germany in the late nineteenth
century. Theodor Lipps (1851–1914)
was one of the first western thinkers
to explore the psychological and
philosophical aspects of Einfühlung.
Lipps’ central concern is what has
come to be known as the “problem of
other minds.” Descartes inaugurated
this problem by insisting that we
could never have true knowledge of
the existence of other minds without
a guarantee from a benevolent
creator. Descartes recognized that
it certainly appeared other people
had minds: thinking, talking, and
writing. But without a guarantee
from God, he could never be certain.
Lipps accepted that this is a serious
philosophical problem, and went
about trying to argue for the existence

of other minds based in the processes
of Einfühlung. In 1909 Edward
Titchener (1867–1927) translated
Einfühlung as “empathy,” coining the
English word.
Contemporary clinical ethicists
may not feel an intellectual kinship
with nineteenth century German
philosophers, but empathy is not so
far from Einfühlung as one might
think. Ethicists often try to discover
the ideas that make up another
person’s view of the world. The
ethicist obviously cannot ask, “Could
you tell me about the concepts that
comprise your mental world?” Even
if the ethicist would venture to ask
such an awkward question, the
ethicist’s tasks require more than an
inventory of a patient’s beliefs. True,
the ethicist often attempts to excavate
and understand the beliefs of the
patient or medical professional, but
more than this, the ethicist hopes to
discover how an individual’s beliefs
inform her ideas about good medicine

and proper action.
More recently, philosophers,
psychologists, and neuroscientists
have become interested in the
possibility that empathy plays a
significant role in understanding not
only the existence of other minds
(Descartes’ problem), but the ways
other minds function in constructing
our own ideas of who we are. We
see this in questions such as: What
is this person going through? What
ideas are found in the mind of the
other person? How should I respond
to them? What does their world say
about my world?
Empathy, as I envision it, begins
with humility. The ethicist must
be willing to set aside her own
conception of what exists and what is
right, temporarily, to try to imagine
the worldview of the patient. This
requires setting aside one’s own
views about wellbeing, suffering, and
proper medical care. For example,
Cont. on page 6
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Cont. from page 5
consider a family member who rejects
the concept of death by neurological
criteria (a.k.a. “brain death”). The
ethicist may believe that this stance
is conceptually problematic, but—
at this point—the ethicist’s goals
involve understanding and relating
to the person who accepts it, not
correcting another’s idea of death.
As part of being an empathetic
presence, the ethicist should aim to
understand the patient’s physical,
psychological, and social-familial
circumstances. One way of beginning
this kind of conversation is by
listening for activities that the patient
finds important and putting these
activities in the context of daily life.
For example, saying something like,
“It sounds like going to temple has
been very important for you. What
other activities do you do most
weeks?” Listening for the actions
the patient considers important will
provide a sense of where she finds
value and meaning in life.
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The ethicist might also ask, when
appropriate, “Could you take me
through what an average day looked
like for you, before you entered the
hospital?” If the patient has been
declining due to illness over time,
the ethicist might ask, “Have you
had any trouble doing these activities
since you started getting sick?”
These activities may involve physical
activities (e.g., hiking a local trail),
mental exertion (e.g., reading or
doing crossword puzzles), and social
interaction (e.g., spending time with
family). Answers to this question
will begin to reveal what the patient
values.
Once the ethicist begins getting a
sense of these values, she can ask,
“What if you could no longer do these
things?” This question will begin to
show how the patient prioritizes these
values. Once the ethicist discovers
this priority, she will be able to begin
constructing an image of the kinds
of actions and values that comprise
the patient’s world—an essential step

in understanding the worldview of
the patient and the kind of life she
was leading. Gradually, a portrait
of a meaningful world may begin to
emerge.
To conclude, it is my hope that
this discussion of empathy—both its
theoretical and practical sides—has
helped clarify the concept and the
practice. We see why it is essential
and challenging: empathy means
becoming invested in the lives
of others while also questioning
ourselves and setting aside our own
beliefs. More than merely revealing
treatment preferences, empathy
requires that medical professionals
encounter patients as people whose
lives extend beyond the confines of
the hospital room.
Trevor M. Bibler, Ph.D., M.T.S.
Assistant Professor of Medicine
Center for Medical Ethics
& Health Policy
Baylor College of Medicine

CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
CASE STUDY – ORAL SUPPLEMENTS AGAINST MEDICAL ADVICE
Mrs. J has been a resident at a Maryland nursing home for the past three years. She is 78 years old, and was diagnosed
with dementia six years ago. Her dementia is now in an advanced stage. She is completely dependent on others for
activities of daily living, and receives nutrition through a PEG tube. Two physicians have certified that she lacks
decisional capacity and is in an end-stage condition. Mrs. J has an advance directive stating that if she is in an end-stage
or terminal condition, that she wants her life to be “prolonged as long as possible within the limits of generally accepted
health-care standards.” Her husband is appointed as her health care agent. Her Medical Orders for Life-Sustaining
Treatment (MOLST) form indicates “Attempt CPR” (there are no orders on page 2). Mr. J believes that her deterioration
is not caused by progressive dementia, but by a biochemical imbalance that he believes can be treated through vitamins
and supplements, including oral colloidal silver, which he has obtained through an online purchase. Mrs. J had been
hospitalized two months earlier for aspiration pneumonia and Mr. J believes the silver supplements will reduce the risk
of this recurring. Mrs. J’s attending physician has told Mr. J that rather than protecting Mrs. J from pneumonia, giving
her any supplements by mouth increases her risk of developing another pneumonia. In addition, colloidal silver can’t be
given through Mrs. J’s PEG tube because this would have to be written as a medical order and the physician won’t write
an order for a supplement that can’t be obtained from the facility’s pharmacy and that doesn’t have data supporting its
safety/purity.
Staff have reported that Mr. J has a volatile temper, which is typically directed toward them in the form of yelling and
name-calling. They observe his behavior toward Mrs. J as generally supportive. While she is not verbally communicative,
staff report that Mrs. J responds positively to her husband’s presence (for example, exhibiting less agitated behaviors
when he is in the room). Mr. J tells staff “I can do whatever I want, she is my wife!” and insists on continuing the silver
and other supplements, which he provides to her through a dropper by mouth. Thus, staff are uncertain what to do: they
feel obligated to protect Mrs. J from harm caused by developing another aspiration pneumonia, but don’t feel comfortable
giving supplements of unknown quality/safety through her PEG tube. The nursing home administrator is considering
banning Mr. J from visiting, or involuntarily discharging Mrs. J. An ethics consultation is requested to help resolve this
dilemma.
RESPONSE FROM SINAI
HOSPITAL ETHICS
COMMITTEE MEMBERS
FACT ANALYSIS
It has been said that “good
ethics begins with good facts”
(Mackiewicz, 2016). The
pertinent medical facts in Mrs.
J’s case are as follows: she is
78 years old with advanced
dementia, progressive over the
past six years. She now lacks
decisional capacity and has a
poor prognosis, deemed end-stage
by two physicians. An “end-stage

condition” is defined in the Maryland
Health Care Decisions Act (HCDA) as
“an advanced, progressive, irreversible
condition caused by injury, disease,
or illness that has caused severe and
permanent deterioration indicated by
incompetency and complete physical
dependency, and for which, to a
reasonable degree of medical certainty,
treatment of the irreversible condition
would be medically ineffective”
(Maryland HCDA).
Mrs. J. was recently hospitalized
for aspiration pneumonia and has no
other significant medical problems.

She resides in a nursing home, is nonambulatory, is fed through a PEG tube
and is dependent on others for all her
activities of daily life.
Mrs. J has a valid advance directive
which specifies that if she is in an
end-stage or terminal condition, she
wants her life to be prolonged “as
long as possible within the limits
of generally accepted health-care
standards.” Her husband, Mr. J, has
been designated as her health care
agent. She also completed a MOLST
form checking the box stating she
wants CPR attempted; she gave no
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other instructions.
Mr. J believes Mrs. J’s mental
deterioration is caused by a
biochemical imbalance which could
be ameliorated by over-the-counter
supplements – vitamins and oral
colloidal silver (OCS). Her physician
will not prescribe OCS because it
is not an FDA-approved drug and
cannot be obtained from the nursing
home’s pharmacy. The facility’s
staff will not administer it through
her PEG tube because of safety and
efficacy concerns and is reluctant
to allow it to be given orally due
to concern for causing aspiration
pneumonia. As a result, Mr. J has
been administering OCS, purchased
legally on-line, to her by mouth
through a dropper.
Mrs. J’s quality of life is quite
limited. It is noted that she appears to
respond favorably to her husband’s
presence and actions by exhibiting
less agitated behaviors when he is
in the room, but no other effects,
favorable or not, are described.
Ethical Analysis
The facts in this case contrast with
those in the more common scenario
involving the withholding of food,
water and other medical care from
a patient with end-stage dementia.
Here, the patient’s designated agent,
her husband, Mr. J, seeks to continue
providing an intervention that the
treating team members believe
is neither safe nor effective. It is
central to our analysis that Mrs. J.
has selected her husband as her
health care agent under her advance
directive, as this evidences her trust
in him and gives him legal authority
to make decisions for her.
The ethical issues revolve around
several considerations. The first is
related to Mrs. J’s physician’s refusal
to prescribe OCS to her as requested
by Mr. J.
OCS is considered a dietary
supplement. The U.S. Food and
Drug Administration regulates
8 Mid-Atlantic Ethics Committee Newsletter

such products under the Dietary
Supplement Health and Education
Act of 1994 (DSHEA), using a
different set of standards from those
applied to conventional foods, drugs
and devices. So long as the product is
not adulterated or misbranded and the
manufacturer makes no therapeutic
claims or misrepresentation about
the efficacy of the product, it may be
legally sold.
According to the National Institutes
of Health, OCS administered orally
has no accepted medical indications
and can cause “serious” side effects,
including argyria, a permanent
discoloration of the skin due to
deposition of silver in the tissues.
“Excessive doses” of the substance
have also been reported to cause
kidney and neurologic disorders
as well as to negatively interact
with certain medicines, none of
which Mrs. J is currently taking.
While anecdotal testimonials, many
described on the Internet, favorably
view the use of OCS for a number
of conditions, including pneumonia,
OCS is not a generally accepted
standard health care treatment.
Following the principle of
beneficence, the physician and
treating staff have no ethical
obligation to provide this modality to
Mrs. J. Furthermore, the principle of
non-maleficence requires that patient
harm must be avoided. On that basis,
even though the potential of OCS to
cause harm is limited, it adds ethical
justification to withhold it from the
patient.
A second consideration is whether
the use of OCS is absolutely
prohibited because it is not
considered safe and effective under
the “generally accepted health care
standards” rubric. The objections of
the physician and nurses caring for
Mrs. J are based on concerns that
aspiration of orally administered
substances pose a potential for harm.
There is no indication of any such
complications related to Mr. J’s

giving her the OCS by dropper, but
we do know she was hospitalized for
aspiration pneumonia in the recent
past.
Current knowledge of the
pathophysiology of aspiration
identifies dysphagia, dementia, and
especially PEG tube feedings as
important risk factors, and, when
pneumonia occurs, it is primarily
related to aspiration of bacteria in
oropharyngeal secretions. Small
amounts of OCS orally via dropper
should not cause significant lung
problems, even if it were to be
aspirated, especially given the fact
that OCS is sometimes administered
without incident by inhalation
intended to reach the lungs.
A third consideration relates to
claims of or liability for abuse if
Mrs. J suffers harm from the OCS
or its administration. Maryland law
does not address the administration
of dietary supplements to patients in
health care institutions, so they are
free to establish policies they believe
to serve the patients’ best interests.
Liability claims resulting from bad
outcomes or harm are always possible
when patients or their families are at
odds with clinicians over a patient’s
care, and end-of-life decisions may be
particularly fraught with such.
In each case, the risks and
benefits of each care option should
be evaluated in the context of the
impact on the patient’s quality of
life. If the patient or decision-maker
chooses to act contrary to a clinician’s
recommendation, discussion among
the parties should take place to
make sure the risks and benefits are
understood. These conversations
should be documented in the medical
record. Signing of releases from
liability are viewed by many in the
legal community as neither helpful
nor enforceable.
Recommendation
In light of Mrs. J’s end-stage
condition and the minimal risks

associated with OCS, it is ethical to
allow its administration to Mrs. J
via the PEG tube, honoring Mr. J’s
wishes.
The situation has led to conflict
and mistrust between Mr. J and
the nursing home staff. As it is not
clear that effective communication
between the parties has occurred,
an ethics consultation team should
meet with all parties. The team
should review the medical facts,
as well as stakeholders’ values and
preferences, and where appropriate,
seek compromise. Educating the
staff about causes of aspiration and
the likely few, if any, adverse effects
caused by the OCS may persuade the
medical team that supplemental OCS
administered via Mrs. J’s PEG tube is
both reasonable and acceptable. If the
treating team remains unwilling, Mr. J
should be permitted to administer the
OCS to Mrs. J in the least intrusive
and most convenient manner. As a
last resort, if compromise cannot be
reached, the physician and nursing
home should assist Mr. and Mrs. J
in finding alternative arrangements
where her husband’s actions on her
behalf will be accommodated.
David L Meyers, MD FACEP
Former Chair, Division of
Emergency Medicine
Member, Sinai Hospital
Ethics Committee
Jeffrey Brauer, MD
Division of Pulmonary &
Critical Care Medicine
Member, Sinai Hospital
Ethics Committee
Yoram Unguru, MD, MS, MA
Division of Pediatric
Hematology/Oncology
The Herman and Walter Samuelson
Children's Hospital at Sinai
Chair, Sinai Hospital
Ethics Committee
Berman Institute of Bioethics,
Johns Hopkins University

THANKS TO: Darlene A. Skinner,
R.N., M.S.N., J.D., CPHRM
Director, Enterprise Risk
and Insurance
Member, Ethics Committee
Sinai Hospital
Alan Eason, JD
Member, Ethics Committee
Sinai Hospital
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COMMENTS FROM AN
ETHICS CONSULTANT
Ethical conflicts in long-term
care facilities often play out over a
protracted period, raising questions
unique to those settings. Providing
“patient/family-centered care”
involves balancing tensions between
respecting a resident’s autonomy
and promoting the resident’s wellbeing and safety—in addition to
meeting federal and state nursing
home regulations and ensuring a
safe environment for staff and other
residents. Based on the case summary
as written, Mrs. J appears to be in the
late stages of dementia (this should
be confirmed). Given that her living
will indicates a preference to receive
life-prolonging interventions “as
long as possible within the limits
of generally accepted health-care
standards,” it is appropriate that she is

receiving feedings through a feeding
(PEG) tube and that her resuscitation
status is “Attempt CPR,” although
this should be revisited as her illness
progresses. While some individuals
opt to focus more on comfort at the
end of a chronic fatal illness like
progressive dementia, it appears the
goals of care for Mrs. J are to prolong
her life. Ideally, she should be kept
as comfortable as possible while
pursuing this goal, and information
about her life narrative would be
elicited to put these important end-oflife decisions into more context.
One concern raised in this case
is whether staff should allow Mr. J
to administer oral supplements of
unknown safety that may increase
Mrs. J’s risk of developing aspiration
pneumonia, or whether staff should
administer these supplements through
Mrs. J’s feeding tube. Given that
Mrs. J is at risk for aspirating and that
she has recently been hospitalized
for aspiration pneumonia, it seems
appropriate that the medical team
recommends against administering
any medication or supplement
orally. The dilemma here is that to
provide the supplements by PEG
tube, a medical order would have
to be written, and in this case, the
supplement that Mr. J wants his wife
to get is likely not available in the
nursing facility’s pharmacy, nor is it
a treatment the facility’s clinicians
would consider “standard medical
care.”
Given the rise in popularity of
“alternative” treatments that can be
acquired over the counter (or in this
case, purchased on the internet),
questions arise about the safety of
these products, which are not subject
to the same regulatory oversight as
drugs approved by the U.S. Food
and Drug Administration (FDA).
Mr. J is convinced that colloidal
silver is benefitting his wife and
should be continued. Palliative care
practitioners recognize that at times,
interventions benefit a patient’s
Mid-Atlantic Ethics Committee Newsletter 9

loved ones as much (or more) than
the patient him/herself. Could staff
allow Mr. J to continue giving the
supplement to Mrs. J based on
this rationale? That is, even if the
colloidal silver wasn’t actually
helping her, if it didn’t harm her, and
gave Mr. J a sense of control and
belief that he was helping her, could
this justify allowing him to continue
giving it? Such a decision requires
considering potential harms. Setting
aside the concern about aspiration if
the supplement was given by mouth,
could the colloidal silver harm Mrs.
J?
Hadrup and Lam (2014) categorize
silver as “non-essential to human
physiology,” although humans are
exposed through contact with silver
coins, tableware, jewelry, dental
fillings, and fish consumption. Mr.
J’s confidence that silver will protect
his wife from contracting pneumonia
is likely informed by information
presented on websites and other
sources touting silver as an antibacterial and anti-inflammatory agent.
While it is true that silver compounds
are used topically to treat wounds,
there is no evidence that ingesting
silver can treat or prevent systemic
infections. Negative effects have been
seen in animal studies at higher doses
(for example, hypoactivity, altered
blood values, enlarged heart, and
immunological effects). It could also
interfere with how other medications
are absorbed. Hadrup and Lam
calculated a “tolerable daily intake”
of 2.5 micrograms per kilogram per
day. Perhaps the fact that no skin
discoloration is noted provides some
evidence that Mrs. J has not received
toxic doses, since excessive silver
exposure manifests through a bluegrey skin discoloration. However,
from this review, it appears that
ingesting colloidal silver presents
more potential harm than benefit.
This information appears to
support the clinicians’ decision not
to order colloidal silver for staff to
10 Mid-Atlantic Ethics Committee Newsletter

administer. But what about taking
action to prevent Mr. J from giving
it to his wife on his own? Allowing
him to do this “on record” would
likely be prohibited by the Code of
Maryland Regulations for long-term
care facilities. But what if he gives it
when staff are not in the room? What
should staff do if they suspect this? If
Mr. J were caring for Mrs. J in their
own home, he could very well give
her over-the-counter supplements
without the knowledge or approval
of the health care team. Would a
health care provider raise concerns
about negligent care or elder abuse in
such a situation? This question could
provide a threshold for considering
how much staff should oppose Mr.
J’s actions in dosing his wife with
the supplement. Since the current
goal of care is to prolong Mrs. J’s
life, including attempting CPR if
needed and treating her aggressively
if she developed pneumonia, it
seems appropriate that the clinicians
recommend against her getting
anything orally. Thus, if Mr. J was
found to be dosing his wife by mouth,
that might warrant more active
opposition from staff. While a risk
of aspiration from comfort feedings
might be allowed if the goal of care
were to maximize her pleasure and
quality of life, since the colloidal
silver isn’t intended to increase Mrs.
J’s comfort or pleasure, but merely
to appease Mr. J in his belief that it’s
providing her benefit, there’s less
justification for not opposing his
actions here. Also, if he were dosing
through the feeding tube, this might
have implications for how facility
staff manage and oversee her care.
The clinical team should explain
their reasoning to Mr. J for omitting
the colloidal silver from Mrs. J’s plan
of care in a way that he is best able to
understand. Perhaps other alternative/
complementary interventions could
be explored for Mrs. J that Mr. J
might find meaningful, such as
aromatherapy or music therapy. How

should staff proceed if they suspect
Mr. J is giving the colloidal silver to
Mrs. J by mouth despite being told
not to do this? Given the depiction
of Mr. J has having a volatile temper,
“policing” or directly confronting
him is ill-advised. Mrs. J appears
comforted by her husband’s presence,
so banning him from her bedside
would deprive her of this (and
would be logistically challenging to
implement). Ultimately, the clinicians
have to evaluate the degree of actual
harm they think Mrs. J is exposed to.
If they conclude that Mr. J’s actions
are too great a threat to Mrs. J, or to
others in the facility if he is unable
to control his anger, options include
involving Adult Protective Services,
seeking guardianship for Mrs. J to
replace Mr. J as his wife’s health care
agent, or pursuing an involuntary
discharge of Mrs. J based on inability
of the facility to meet her welfare
and needs, or concern that the health
of individuals in the facility are
endangered by her continued stay
(MD Code Health-General §19345). Ideally, the process of ethics
consultation would uncover a less
drastic resolution to this situation.
For example, a behavioral contract
could be negotiated between Mr. J
and staff to establish expectations
of their interactions. Sometimes
the “difficult” family member is
simply one who has not felt heard,
understood, or respected. Other
times, family members cross lines
despite best efforts of staff to work
with them to do what’s best for the
patient. All the stakeholders in this
case deserve consideration of what’s
best for Mrs. J and what reasonable
accommodations look like in meeting
her goals of care.
Anita J. Tarzian, PhD, RN
MHECN Program Coordinator
Ethics & Research Consultant
Baltimore, MD

CALENDAR OF EVENTS
JANUARY

Winter 2018

22 (4-5:30PM)
Clinical Ethics Case Consultation Webinar: Tips and Pitfalls,
sponsored by the Center for Medical Ethics and Health Policy at
Baylor College of Medicine. Visit: events.houstonmethodist.org/
webinar-bioethics.
26 (10A-12N)
Meeting of the State Advisory Council on Quality Care at
the End of Life, executive conference room at the Office
of Health Care Quality in the Bland Bryant Building,
Spring Grove Campus, Catonsville, MD. For campus map/
directions, visit: https://health.maryland.gov/ohcq/Documents/
MapofSpringGrove.jpeg.
FEBRUARY
8-10
Conflict Resolution and Clinical-Setting Mediation for
Healthcare, sponsored by the Center for Conflict Resolution
in Healthcare, Memphis, TN. Visit: http://www.healthcaremediation.net/registration.html.
28 – March 2
Carol Carfang Nursing & Healthcare Ethics Conference,
sponsored by Duquesne University School of Nursing,
Clearwater, FL. Visit: http://duq.edu/academics/schools/nursing/
carfang-conference.
MARCH
1-4
Ethics and Error in Medicine. Annual Meeting of the
Association for Practical and Professional Ethics. Chicago, IL.
Visit: http://appe-ethics.org/.
2
Pellegrino Seminar on the Philosophy of Medicine, Georgetown
University, Washington, DC. Visit: http://www.cvent.com/d/
qtqkny/4W.
APRIL
12-13
Fifty Years After the Harvard Report on Brain Death:
Consensus, Controversy, and the Future of Organ
Transplantation, sponsored by Harvard University, Boston, MA.
Visit: http://bioethics.hms.harvard.edu/.
13-14
Third Annual Reproductive Ethics Conference, sponsored by
the Alden March Bioethics Institute & Department of Obstetrics
& Gynecology, Albany Medical College, Albany, NY. Visit:
https://www.amc.edu/academic/bioethics/reproductive_ethics/
reproductiveethicsconference.cfm.
13-15
Age and Longevity in the 21st Century: Science, Policy and

Ethics, sponsored by the Global Bioethics Initiative,
New York, NY. Visit: http://www.conferenceaging.
org.
13-15
Examining the Foundations of Medicine and
Religion, Union Station Hotel, St. Louis, MO. Visit:
www.medicineandreligion.com.
16-18
Intensive Bioethics Course, Houston, TX (see Jan 22
event above for sponsorship and contact info).

RECURRING EVENTS
Johns Hopkins Berman Institute of Bioethics
Seminar Series, either at Sheik Zayed Tower Chevy
Chase Conference Center (1800 Orleans St.) or
Feinstone Hall, E2030, Bloomberg School of
Public Health (615 N. Wolfe St.) Baltimore, MD.
12N-1:15PM. Visit: http://www.bioethicsinstitute.
org/educationtraining-2/seminar-series.
January 22- Speaker: Eric Dishman, Director, All
of U.S. Research Program on Precision Medicine
(Zayed)
February 12- Speaker: Juan Mendez, JD, Professor
of Human Rights Law In Residence, Washington
College of Law (Feinstone Hall)
February 26- Speaker: Anne Barnhill, PhD,
Assistant Professor, Medical Ethics and Health
Policy, Perelman School of Medicine, University of
Pennsylvania (Feinstone Hall)
March 12- Speaker: Christine Mitchell, MTS, MS,
FAAN, Executive Director, Center for Bioethics,
Harvard Medical School (Hutzler-Rives Memorial
Lecture; Zayed)
March 26- Speaker: Hilde Lindemann, PhD, MA,
Professor of Philosophy, Michigan State University
(Feinstone Hall)
April 9- Speaker: David DeGrazia, PhD, M.Stud,
Professor of Philosophy, George Washington
University & Senior Research Fellow, Department
of Bioethics, National Institutes of Health (Feinstone
Hall)
April 23- Speaker: Kathleen Meert, MD, FCCM,
Chief, Division of Critical Care Medicine, Professor,
Department of Pediatrics, Children’s Hospital of
Michigan (Hutzler-Rives Memorial Lecture; Zayed)
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The Law & Health Care Program
Maryland Health Care Ethics
Committee Network
University of Maryland
Francis King Carey School of Law
500 W. Baltimore Street
Baltimore, MD 21201

The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by the Law and
Health Care Program at the University of Maryland Francis King Carey School of Law. The purpose of MHECN is to facilitate
and enhance ethical reflection in all aspects of decision making in health care settings by supporting and providing informational
and educational resources to ethics committees serving health care institutions in the state of Maryland. The Network attempts to
achieve this goal by:
•

Serving as a resource to ethics committees as they investigate ethical dilemmas within their institution and as they strive to
assist their institution act consistently with its mission statement;

•

Fostering communication and information sharing among Network members;

•

Providing educational programs for ethics committee members, other healthcare providers, and members of the general
public on ethical issues in health care; and

•

Conducting research to improve the functioning of ethics committees and ultimately the care of patients in Maryland.

MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from affiliate
members who provide additional financial support.
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